Proton Pump Inhibitors and Fat Absorption in Cystic Fibrosis and Exocrine Pancreatic Insufficiency

Об исследовании

This is a clinical trial with a cross over design investigating the effect of the proton pump inhibitor omeprazole on fat malabsorption in subjects with cystic fibrosis and pancreatic insufficiency. Participants will be randomized to receive either omeprazole or placebo for 28 days, then cross over and receive omeprazole or placebo for another 28 days. Markers of fat absorption will be measured after each treatment course.

Открыть NCT03551691 на ClinicalTrials.gov →

Связанные материалы